Skip to main content

Advertisement

SpringerLink
Log in

Basal Phenotype in Breast Carcinoma Occurring in Women Aged 35 or Younger

  • Original Paper
  • Published:
Pathology & Oncology Research

Abstract

Breast cancer in the young is considered a special clinical presentation of the disease. Sixty-nine breast cancer cases diagnosed at or before the age of 35 were analyzed for common morphological and immunophenotypical features of basal-like carcinomas. Sixteen carcinomas displayed the immunophenotypical characteristics (estrogen receptor and HER2 negativity and positivity for at least one of the following basal markers: cytokeratin 5 or 14, epidermal growth factor receptor, p63) of basal-like carcinomas, and most of them demonstrated characteristic histological features (pushing borders, lymphocytic peritumoral infiltrate, central hypocellular zone or necrosis, high mitotic rate) too. These tumors were more likely to be high-molecular-weight cytokeratin: 34betaE12 and p53 positive by immunohistochemistry. The presence of a basal-like phenotype can be important as concerns systemic treatment issues and could theoretically be associated with a higher rate of BRCA1 mutations in the young, because of the overlap of BRCA1 mutation associated breast carcinomas and the basal-like phenotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fernandopulle SM, Cher-Siangang P, Tan PH (2006) Breast carcinoma in women 35 years and younger: a pathological study. Pathology 38:219–222

    Article  PubMed  Google Scholar 

  2. Figueiredo JC, Ennis M, Knight JA et al (2007) Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Res Treat 105:69–80

    Article  PubMed  Google Scholar 

  3. Armes JE, Egan AJ, Southey MC et al (1998) The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer 83:2335–2345

    Article  PubMed  CAS  Google Scholar 

  4. Bennett IC, Freitas R Jr, Fentiman IS (1991) Diagnosis of breast cancer in young women. Aust N Z J Surg 61:284–289

    Article  PubMed  CAS  Google Scholar 

  5. Tai P, Cserni G, Van de Steene J et al (2005) Modeling the effect of age in T1-T2 breast cancer using the SEER database. BMC Cancer 5:130. doi:10.1186/1471-2407-5-130

    Article  PubMed  Google Scholar 

  6. Trecate G, Vergnaghi D, Manoukian S et al (2006) MRI in the early detection of breast cancer in women with high genetic risk. Tumori 92:517–523

    PubMed  Google Scholar 

  7. Golshan M, Miron A, Nixon AJ (2006) The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. Am J Surg 192:58–62

    Article  PubMed  CAS  Google Scholar 

  8. Lubiński J, Górski B, Huzarski T et al (2006) BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat 99:71–76

    Article  PubMed  Google Scholar 

  9. Loizidou M, Marcou Y, Anastasiadou V et al (2007) Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus. Clin Genet 71:165–170

    Article  PubMed  CAS  Google Scholar 

  10. Foulkes WD, Brunet JS, Stefansson IM et al (2004) The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res 64:830–835

    Article  PubMed  CAS  Google Scholar 

  11. Foulkes WD, Metcalfe K, Sun P et al (2004) Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 10:2029–2034

    Article  PubMed  CAS  Google Scholar 

  12. Laakso M, Loman N, Borg A et al (2005) Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors. Mod Pathol 18:1321–1328

    Article  PubMed  CAS  Google Scholar 

  13. Lakhani SR, Reis-Filho JS, Fulford L et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11:5175–5180

    Article  PubMed  CAS  Google Scholar 

  14. Lidereau R, Eisinger F, Champeme MH et al (2000) Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res 60:1206–1210

    PubMed  CAS  Google Scholar 

  15. Foulkes WD, Stefansson IM, Chappuis PO et al (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95:1482–1485

    PubMed  CAS  Google Scholar 

  16. Fulford LG, Easton DF, Reis-Filho JS et al (2006) Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 49:22–34

    Article  PubMed  CAS  Google Scholar 

  17. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869–10874

    Article  PubMed  CAS  Google Scholar 

  18. Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100:8418–8423

    Article  PubMed  CAS  Google Scholar 

  19. Nielsen TO, Hsu FD, Jensen K et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367–5374

    Article  PubMed  CAS  Google Scholar 

  20. Bauer KR, Brown M, Cress RD et al (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109:1721–1728

    Article  PubMed  Google Scholar 

  21. Rakha EA, El-Sayed ME, Green AR et al (2007) Prognostic markers in triple-negative breast cancer. Cancer 109:25–32

    Article  PubMed  CAS  Google Scholar 

  22. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410

    Article  PubMed  CAS  Google Scholar 

  23. Ellis IO, Pinder SE, Bobrow L et al (2005) Pathology reporting of breast disease. NHS Publication No 58. Sheffield: NHS Cancer Screening Programmes and the Royal College of Pathologists. Accessed at 12 July 2007. http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp58-low-resolution.pdf

  24. DakoCytomation. HercepTestTM, 8th ed. Accessed at 12 July 2007. http://dist.dako.com/prod_downloadpackageinsert.pdf?objectid=105073005

  25. Takei H, Iino Y, Horiguchi J et al (1997) Low and high molecular weight cytokeratins in invasive breast carcinoma. Oncol Rep 4:33–38

    CAS  Google Scholar 

  26. Ridolfi RL, Rosen PP, Port A et al (1977) Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 40:1365–1385

    Article  PubMed  CAS  Google Scholar 

  27. Tot T (2000) The cytokeratin profile of medullary carcinoma of the breast. Histopathology 37:175–181

    Article  PubMed  CAS  Google Scholar 

  28. Jacquemier J, Padovani L, Rabayrol L et al (2005) Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol 207:260–268

    Article  PubMed  CAS  Google Scholar 

  29. Reis-Filho JS, Milanezi F, Steele D et al (2006) Metaplastic breast carcinomas are basal-like tumours. Histopathology 49:10–21

    Article  PubMed  CAS  Google Scholar 

  30. Tsuda H, Takarabe T, Hasegawa F et al (2000) Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol 24:197–202

    Article  PubMed  CAS  Google Scholar 

  31. Bratthauer GL, Miettinen M, Tavassoli FA (2003) Cytokeratin immunoreactivity in lobular intraepithelial neoplasia. J Histochem Cytochem 51:1527–1531

    PubMed  CAS  Google Scholar 

  32. van ’t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530–536

    Article  PubMed  Google Scholar 

  33. Banerjee S, Reis-Filho JS, Ashley S et al (2006) Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 59:729–735

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Bács-Kiskun County Teaching Hospital, Nyíri út 38., 6000, Kecskemét, Hungary

    Rita Bori & Gábor Cserni

Authors
  1. Rita Bori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gábor Cserni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rita Bori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bori, R., Cserni, G. Basal Phenotype in Breast Carcinoma Occurring in Women Aged 35 or Younger. Pathol. Oncol. Res. 15, 41–45 (2009). https://doi.org/10.1007/s12253-008-9090-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-008-9090-4

Keywords

Search

Navigation